Version May 2024
| Tumor pathology | All patients, n (%) | Patients from oncology centers, n (%) | Patients from other hospitals, n (%) |
| All benign pathologies | 3183 (65.7) | 1861 (57.0) | 1322 (83.4) |
| Endometrioma | 845 (17.4) | 456 (14.0) | 389 (24.5) |
| Benign teratoma (dermoid) | 512 (10.6) | 334 (10.2) | 178 (11.2) |
| Simple/parasalpingeal cyst | 285 (5.9) | 147 (4.5) | 138 (8.7) |
| Functional cyst | 128 (2.6) | 69 (2.1) | 59 (3.7) |
| Hydrosalpinx | 112 (2.3) | 53 (1.6) | 59 (3.7) |
| Peritoneal pseudocyst | 34 (0.7) | 21 (0.6) | 13 (0.8) |
| Abscess | 45 (0.9) | 34 (1.0) | 11 (0.7) |
| Fibroma | 245 (5.1) | 168 (5.1) | 77 (4.9) |
| Serous cystadenoma | 543 (11.2) | 326 (10.0) | 217 (13.7) |
| Mucinous cystadenoma | 359 (7.4) | 203 (6.2) | 156 (9.8) |
| Rare benign pathologies | 75 (1.5) | 50 (1.5) | 25 (1.6) |
| All malignant pathologies | 1665 (34.3) | 1402 (43.0) | 263 (16.6) |
| Primary invasive stage I | 222 (4.6) | 184 (5.6) | 38 (2.4) |
| Primary invasive stage II | 82 (1.7) | 64 (2.0) | 18 (1.1) |
| Primary invasive stage III | 658 (13.6) | 579 (17.7) | 79 (5.0) |
| Primary invasive stage IV | 102 (2.1) | 88 (2.7) | 14 (0.9) |
| Rare primary invasive pathologies* | 113 (2.3) | 80 (2.5) | 33 (2.1) |
| Borderline stage I | 249 (5.1) | 197 (6.0) | 52 (3.3) |
| Borderline stage II | 9 (0.2) | 6 (0.2) | 3 (0.2) |
| Borderline stage III | 25 (0.5) | 23 (0.7) | 2 (0.1) |
| Borderline stage IV | 1 (0.02) | 1 (0.03) | 0 |
| Secondary metastatic cancer | 204 (4.2) | 180 (5.5) | 24 (1.5) |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
